Cytotoxic and Antioxidant Activities of Imine Analogs of Trans-Resveratrol towards Murine Neuronal N2a Cells

Molecules. 2022 Jul 23;27(15):4713. doi: 10.3390/molecules27154713.

Abstract

Trans-resveratrol is a natural polyphenol showing numerous biological properties, especially anti-tumoral and antioxidant activity. Among numerous resveratrol derivatives, aza-stilbenes, which bear an imine bound, show interesting biological activities. In the present study, we synthesized a series of imine analogs of trans-resveratrol (seven aza-stilbenes) following an easy and low-cost procedure of green chemistry. The toxicity of synthesized aza-stilbenes, which is currently unknown, was evaluated on murine neuronal N2a cells, comparatively to trans-resveratrol, by considering: cell density evaluated by staining with sulforhodamine 101; esterase activity, which is a criteria of cell viability, by staining with fluorescein diacetate; and transmembrane mitochondrial potential, which is known to decrease during cell death, by staining with DiOC6(3) using flow cytometry. In addition, the antioxidant activity was quantified with the KRL (Kit Radicaux Libres) assay, the DPPH (2,2'-diphenyl-1-picrylhydrazyl radical) assay and the FRAP (ferric reducing antioxidant power) assay. The PAOT (Pouvoir Antioxidant Total) score was also used. The aza-stilbenes provide different cytotoxic and antioxidant activities, which are either higher or lower than those of trans-resveratrol. Based on their cytotoxic and antioxidant characteristics, all synthesized aza-stilbenes are distinguished from trans-resveratrol.

Keywords: antioxidant activity; aza-stilbenes synthesis; cytotoxicity; murine neuronal N2a cells; trans-resveratrol.

MeSH terms

  • Animals
  • Antineoplastic Agents* / chemistry
  • Antioxidants / chemistry
  • Antioxidants / pharmacology
  • Imines / pharmacology
  • Mice
  • Resveratrol / pharmacology
  • Stilbenes* / chemistry
  • Stilbenes* / pharmacology

Substances

  • Antineoplastic Agents
  • Antioxidants
  • Imines
  • Stilbenes
  • Resveratrol

Grants and funding

This research was funded by Université de Bourgogne (G.L., A.V., D.V.-F.), Région Bourgogne Franche-Comté (Projet MEDICTA, Appel à Projet Région 2020, G.L., A.V., D.V.-F.), Institut de Chimie Moléculaire de l’Université de Bourgogne ICMUB UMR CNRS 6302 (D.V.-F.). M.K. received financial support from PHC Utique (G.L./T.G. and O.M.-K.; 2021–2022; code CMCU22G089/code Campus France 47608V).